Product Images Fluvoxamine Maleate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Fluvoxamine Maleate NDC 31722-064 by Camber Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
fluvoxaminelabel100mg30s - fluvoxaminelabel100mg30s
This is a description for a medication called CAMBE, which is an Extended-Release Capsule containing Fluvoxamine Maleate in 100 mg strength. The prescription is to be dispensed in a tight, light-resistant container and stored at temperatures between 20° to 25°C. Extended-Release capsules should not be crushed or chewed. The manufacturer is Camber Pharmaceuticals, Inc. with contact information provided. Additional details and guidelines can be found in the prescribing information and medication guide available online.*
fluvoxaminelabel150mg30s - fluvoxaminelabel150mg30s
This is a description of a medication called "Camber" with the NDC code 31722-065-30, which consists of fluvoxamine maleate in extended-release capsules of 150 mg strength. The pharmacist is instructed to dispense this medication with the Medication Guide to each patient. It is advised to store the capsules in a tight, light-resistant container at room temperature. The usual dosage information and boxed warning should be reviewed before use. The manufacturer is indicated as Camber Pharmaceuticals, located in Telangana, India, with additional information provided for inquires and access to the Medication Guide.*
fluvoxaminelogo - fluvoxaminelogo
fluvoxaminestructure - fluvoxaminestructure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
